NO159170C - Analogifremgangsmaate for fremstilling av terapeutisk aktive diazin-forbindelser. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive diazin-forbindelser.

Info

Publication number
NO159170C
NO159170C NO840214A NO840214A NO159170C NO 159170 C NO159170 C NO 159170C NO 840214 A NO840214 A NO 840214A NO 840214 A NO840214 A NO 840214A NO 159170 C NO159170 C NO 159170C
Authority
NO
Norway
Prior art keywords
compounds
diazin
preparation
image
therapeutically active
Prior art date
Application number
NO840214A
Other languages
English (en)
Norwegian (no)
Other versions
NO159170B (no
NO840214L (no
Inventor
Kathleen Biziere
Jean-Pierre Chambon
Andre Hallot
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO840214L publication Critical patent/NO840214L/no
Publication of NO159170B publication Critical patent/NO159170B/no
Publication of NO159170C publication Critical patent/NO159170C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Catalysts (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Polymerisation Methods In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO840214A 1983-01-21 1984-01-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive diazin-forbindelser. NO159170C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8300954A FR2539741A1 (fr) 1983-01-21 1983-01-21 Composes a noyau heterocyclique diazote, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent

Publications (3)

Publication Number Publication Date
NO840214L NO840214L (no) 1984-07-23
NO159170B NO159170B (no) 1988-08-29
NO159170C true NO159170C (no) 1988-12-07

Family

ID=9285183

Family Applications (1)

Application Number Title Priority Date Filing Date
NO840214A NO159170C (no) 1983-01-21 1984-01-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive diazin-forbindelser.

Country Status (30)

Country Link
US (1) US4624952A (xx)
EP (1) EP0114770B1 (xx)
JP (1) JPS59137469A (xx)
KR (1) KR910000640B1 (xx)
AT (1) ATE28453T1 (xx)
AU (1) AU563160B2 (xx)
CA (1) CA1217490A (xx)
CS (1) CS242894B2 (xx)
DD (1) DD216014A5 (xx)
DE (1) DE3464909D1 (xx)
DK (1) DK25684A (xx)
EG (1) EG16212A (xx)
ES (1) ES8407040A1 (xx)
FI (1) FI79537C (xx)
FR (1) FR2539741A1 (xx)
GR (1) GR79766B (xx)
HU (1) HU191586B (xx)
IE (1) IE56569B1 (xx)
IL (1) IL70740A (xx)
MA (1) MA20007A1 (xx)
NO (1) NO159170C (xx)
NZ (1) NZ206906A (xx)
OA (1) OA07638A (xx)
PH (1) PH21060A (xx)
PL (1) PL143224B1 (xx)
PT (1) PT77966B (xx)
SG (1) SG2189G (xx)
SU (1) SU1342415A3 (xx)
YU (1) YU10384A (xx)
ZA (1) ZA84342B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
FR2567518B1 (fr) * 1984-07-11 1987-11-13 Sanofi Sa Nouveaux composes a noyau heterocyclique azote, leur preparation et les medicaments qui en contiennent
DE3517617A1 (de) * 1985-05-15 1986-11-20 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Neue pyridaziniumverbindungen, verfahren zu deren herstellung und diese enthaltende fungizide und algizide mittel
US5106973A (en) * 1987-11-23 1992-04-21 Janssen Pharmaceutica N.V. Pyridzainamine derivatives
FI895821A0 (fi) * 1988-12-07 1989-12-05 Wellcome Found Farmaceutiskt aktiva cns foereningar.
US5631255A (en) * 1989-02-07 1997-05-20 Sanofi Pyridazine derivatives
FR2676444B1 (fr) * 1991-05-16 1995-03-10 Sanofi Elf Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant.
US5952331A (en) * 1996-05-23 1999-09-14 Syntex (Usa) Inc. Aryl pyrimidine derivatives
US5958934A (en) * 1996-05-23 1999-09-28 Syntex (U.S.A.) Inc. Aryl pyrimidine derivatives and uses thereof
TW440563B (en) * 1996-05-23 2001-06-16 Hoffmann La Roche Aryl pyrimidine derivatives and a pharmaceutical composition thereof
WO2008096746A1 (ja) * 2007-02-06 2008-08-14 Takeda Pharmaceutical Company Limited スピロ化合物およびその用途
CN107614503B (zh) * 2015-04-29 2020-03-10 广东众生药业股份有限公司 稠环或三环芳基嘧啶化合物用作激酶抑制剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1345880A (en) * 1971-06-18 1974-02-06 Cepbepe Pyridazine derivatives
US4302455A (en) * 1980-04-14 1981-11-24 Merck & Co., Inc. 2-(4-Aminopiperidino)pyrazines
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
FR2511366A1 (fr) * 1981-08-11 1983-02-18 Sanofi Sa Nouveaux derives de la pyridazine, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent

Also Published As

Publication number Publication date
FI79537C (fi) 1990-01-10
FI79537B (fi) 1989-09-29
YU10384A (en) 1986-10-31
PT77966A (fr) 1984-02-01
SU1342415A3 (ru) 1987-09-30
ZA84342B (en) 1984-08-29
GR79766B (xx) 1984-10-31
EG16212A (en) 1989-06-30
NO159170B (no) 1988-08-29
ES528921A0 (es) 1984-09-01
NO840214L (no) 1984-07-23
DD216014A5 (de) 1984-11-28
KR910000640B1 (ko) 1991-01-31
EP0114770B1 (en) 1987-07-22
DK25684A (da) 1984-07-22
MA20007A1 (fr) 1984-10-01
FR2539741B1 (xx) 1985-05-17
DE3464909D1 (en) 1987-08-27
EP0114770A2 (fr) 1984-08-01
ATE28453T1 (de) 1987-08-15
AU2323684A (en) 1984-07-26
AU563160B2 (en) 1987-07-02
PT77966B (fr) 1986-07-11
IE56569B1 (en) 1991-09-11
IE840102L (en) 1984-07-21
FR2539741A1 (fr) 1984-07-27
DK25684D0 (da) 1984-01-20
CA1217490A (en) 1987-02-03
OA07638A (fr) 1985-05-23
PL143224B1 (en) 1988-01-30
EP0114770A3 (en) 1984-08-22
SG2189G (en) 1989-06-02
ES8407040A1 (es) 1984-09-01
PH21060A (en) 1987-07-10
US4624952A (en) 1986-11-25
FI840238A (fi) 1984-07-22
NZ206906A (en) 1987-05-29
CS42484A2 (en) 1985-08-15
IL70740A0 (en) 1984-04-30
CS242894B2 (en) 1986-05-15
PL245836A1 (en) 1985-07-02
FI840238A0 (fi) 1984-01-20
HU191586B (en) 1987-03-30
JPS59137469A (ja) 1984-08-07
IL70740A (en) 1986-09-30
KR840007406A (ko) 1984-12-07

Similar Documents

Publication Publication Date Title
IT1063768B (it) Procedimento perfezionato per la fabbricazione di dispositivi semiconduttori
NO159170C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazin-forbindelser.
FR2320300A1 (fr) Procede de preparation de chromanones-(4)
BE844943A (fr) Procede de preparation de chromanones-(4)
OA05405A (fr) Procédé de préparation de composés pharmacologiquement actifs.
FR2327995A1 (fr) Procede ameliore de preparation de vanadate d'ethyle
FR2314192A1 (fr) Procede de preparation d'oxaphospholannes-1,2
OA05260A (fr) Procédé de préparation de dérivés d'histidine.
OA05404A (fr) Procédé de préparation de composés pharmocologiquement actifs.
BE837906A (fr) Procede de preparation de n-(alpha-alcoxyethyl)-carboxamides
OA05206A (fr) Procédé de préparation de dérivés d'amines.
ZA764225B (en) Distillative purification of 2,5-dioxo-1-oxa-2-phospholanes
FR2306198A1 (fr) Procede discontinu de preparation de l'iminodiacetonitrile
PT65165B (fr) Noveau procede de preparation du n-(l-ethyl-2-pyrrolidylmethyl)-2-methoxy-5-sulfamoyl-benzamide
FR2317307A1 (fr) Procede de preparation d'oxaphospholannes-1,2
FR2336377A1 (fr) Procede de preparation de la n-(3,4-dimethylphenyl)-d-ribamine
BE849390A (fr) Procede de preparation de la n-(3,4-dimethylphenyl)-d-ribamine
SE7600178L (sv) Forfarande for framstellning av komplex av metaller ur den 7:e gruppen i det periodiska systemet
BE845867A (fr) Procede de preparation de l'iminodiacetonitrile
FR1239989A (fr) Procédé de préparation de dérivés amidés de l'acide phosphorique
FR1298571A (fr) Procédé de préparation de dérivés substitués à l'azote de la carbéthoxy-pyrrolidone
FR1268470A (fr) Procédé de préparation d'amides aromatiques ortho-disubstituées
FR81902E (fr) Procédé de préparation de nouveaux dérivés d'antibiotiques basiques